Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Novel tricyclic diterpene synthesis patent CN104557602B offers high selectivity and mild conditions for scalable anticancer intermediate manufacturing.
Novel diethylene glycol route for high-purity 4-(4-aminophenyl)morpholine-3-one. Cost-effective, scalable Rivaroxaban intermediate manufacturing with reduced waste.
Novel nitrilase enables efficient production of chiral intermediates for clopidogrel with reduced environmental impact and scalable supply chain solutions.
Patent CN101155801A details a Pd-catalyzed borylation route for high-purity indole intermediates, offering significant cost reduction in pharmaceutical manufacturing and scalable supply chain solutions.
Patent CN101948404B reveals a greener route for Ioxilan intermediates. Discover cost reduction in API manufacturing and high-purity production strategies.
Patent CN113717071B details a metal-free visible light catalytic method for acetamide compounds, offering cost reduction and scalable supply chain solutions for pharmaceutical intermediates.
Patent CN112359079B reveals a novel enzymatic route for Imatamine. Achieve high purity and cost reduction in API manufacturing with our scalable green chemistry solutions.
High-purity S-tetrahydrofuranic acid via enzymatic resolution. Superior yield and optical purity for pharmaceutical intermediates supply chain.
Patent CN104232696A reveals biocatalytic method for high-purity chiral alcohol. Offers cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel triazole IDO inhibitor synthesis patent CN109748911A offers improved yield and purity for pharmaceutical intermediate manufacturing supply chains globally.
Patent CN105985292B enables mild asymmetric catalysis. Delivers high-purity pharmaceutical intermediates with substantial cost reduction and supply chain reliability.
Novel squaramide-catalyzed route for halogenated dihydropyranopyrrolones. High yield, mild conditions, antitumor activity. Ideal for API intermediates.
Patent CN103483256A details a novel synthetic route for (-)-FABA, an oxidized aporphine alkaloid derivative with potent antitumor activity, offering scalable manufacturing solutions.
Novel synthesis of 4-(4-aminophenyl)-3-morpholinone via iron reduction. Cost-effective, scalable route for API intermediates avoiding noble metals.
Patent CN107098866A reveals cost-effective chemical resolution for Lesinurad enantiomers ensuring high purity and supply chain stability for pharmaceutical manufacturing partners globally.
Patent CN107098866A offers cost-effective chiral resolution for Lesinurad intermediates, ensuring high purity and scalable supply chain solutions for global pharmaceutical manufacturing.
Patent CN106748888B reveals a safer route for sitagliptin intermediates. Reduces explosive risks and costs for reliable pharmaceutical intermediate suppliers.
Patent CN112047841B details a continuous esterification method for reduced coenzyme Q10 acetate, offering high purity, catalyst recycling, and superior stability for pharmaceutical supply chains.
Patent CN101386588B reveals a low-temperature isomerization method for high-purity cilastatin acid intermediates, offering significant cost reduction and supply reliability for pharmaceutical manufacturers.
Patent CN105801573B reveals high-yield cyclization for Berberine intermediates. Offers scalable, cost-effective manufacturing solutions for global pharmaceutical supply chains.